Benefit of Selective Factor Inhibition Journal Articles

authors

• Turpie, Alexander Graham Gri
• Büller, Harry R

status

• published 

publication date

• 2002

has subject area

• 1103 Clinical Sciences (FoR)
• Antithrombin III (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• Clinical Trials as Topic (MeSH)
• Drug Design (MeSH)
• Fondaparinux (MeSH)
• Heparin, Low-Molecular-Weight (MeSH)
• Humans (MeSH)
• Polysaccharides (MeSH)
• Substrate Specificity (MeSH)
• Thrombin (MeSH)
• Thromboembolism (MeSH)

published in

• Seminars in Thrombosis and Hemostasis  Journal

keywords

• Antithrombin III
• Clinical Trials as Topic
• Drug Design
• Fondaparinux
• Heparin, Low-Molecular-Weight
• Humans
• Polysaccharides
• Substrate Specificity
• Thrombin
• Thromboembolism

Digital Object Identifier (DOI)

• 10.1055/s-2002-32316

PubMed ID

• 12073180

start page

• 049

end page

• 050

volume

• 28

issue

• s2